Marinus Pharma News, Marinus Pharma Quote, MRNS Quote

Marinus Pharma (NQ:MRNS) Delayed: 1.41 --0 (-0%)

Prev. Close

$1.41

Open

$1.41

52 Wk High

$8.12

52 Wk Low

$1.02

Day High

$1.41

Day Low

$1.41

P/E

N/A

EPS

$0.00

Volume

38,952

Friends, Peers and Foes (?): NKTR DMAC (more...)

Apr 19, 2024 06:06 AM Form SC 13G MARINUS PHARMACEUTICALS, Filed by: TANG CAPITAL PARTNERS LP
Apr 17, 2024 10:54 AM Marinus Pharmaceuticals (MRNS) PT Lowered to $10 at Truist Securities
Apr 16, 2024 06:31 AM Marinus Pharmaceuticals (MRNS) PT Lowered to $13 at Cantor Fitzgerald
Apr 16, 2024 03:06 AM Baird Downgrades Marinus Pharmaceuticals (MRNS) to Neutral, 'Phase 3 RAISE Study Doesn't Hit at Interim'
Apr 15, 2024 12:54 PM RBC Capital Downgrades Marinus Pharmaceuticals (MRNS) to Sector Perform
Apr 15, 2024 12:53 PM Marinus Pharmaceuticals (MRNS) PT Lowered to $4 at Ladenburg Thalmann
Apr 15, 2024 07:32 AM Form 8-K MARINUS PHARMACEUTICALS, For: Apr 15
Apr 15, 2024 07:01 AM Marinus Pharma (MRNS) phase 3 RAISE trial did not meet pre-defined stopping criteria at the interim analysis
Apr 15, 2024 07:00 AM Marinus Pharmaceuticals Provides Update on the Phase 3 RAISE Trial and Reports Preliminary First Quarter 2024 Financial Results
Apr 15, 2024 06:55 AM Marinus Pharma (MRNS) Halted, News Pending

Entities mentioned with MRNS